<qa>  Prior monoclonal antibody within 4 weeks prior to study Day 1 or who has not recovered9. Prior monoclonal antibody within 4 weeks prior to study Day 1 or who has not recovered i.e. Grade 1 or at baseline from adverse events due to agents adverse events administered more than 4 weeks earlier. 